Takeda Pharmaceutical Co - ADR XNYS: TAK

Takeda pharma Co (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Takeda Pharmaceutical Co - ADR: Is Infosys Ltd. worth buying?
Item: Takeda Pharmaceutical Co - ADR
Rating: 2.285611
Author: Trendlyne DVM scores

Expensive Rocket

about

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, whi...

16.91 0.30 (1.81%)

New 52W High today

3.9M

XNYS Volume

XNYS 27 Jan, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for Takeda pharma Co (ADR) is on 30 Jan 2026 for the purpose of Takeda Pharmaceutical Co Ltd Third Quarter Earnings Results for 2025 See details

Medium Financial Strength

44.4 / 100

Expensive Valuation

28.5 / 100

Technically Moderately Bullish

65.5 / 100

Expensive Rocket These stocks have good momentum, but are expensive with average financials View Similar Embed DVM

1Yr Price target upside is 14%

3 analysts

Takeda pharma Co (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..